Andrew Spaventa

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
La Jolla, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Dalen Meeter, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Andrew Spaventa

Form 4 holding Chief Executive Officer, Director

Singular Genomics Systems, Inc.

Security class
Restricted Stock Units
Shares / value
22,873
Estimated value
$454,944
Report date
12 Feb 2025
Price
$19.89
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Singular Genomics Systems, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
21 Feb 2025
Price
$19.89
Ownership
By Axon Holdings, LLC
Form 4 holding Chief Executive Officer, Director

Singular Genomics Systems, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
21 Feb 2025
Price
$19.89
Ownership
By The Andrew K. Spaventa Living Trust dated April 9, 2014
Form 4 holding Chief Executive Officer, Director

Singular Genomics Systems, Inc.

Security class
Restricted Stock Unit
Shares / value
0
Estimated value
$0
Report date
21 Feb 2025
Price
$20.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Singular Genomics Systems, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
$0
Report date
21 Feb 2025
Price
$1.10
Ownership
By The Andrew K. Spaventa Living Trust dated April 9, 2014
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Andrew Spaventa

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .